Horizon Pharma plc (HZNP)

24.92
0.32 1.30
NASDAQ
Prev Close 24.60
Open 24.57
Day Low/High 24.12 / 25.06
52 Wk Low/High 12.55 / 24.03
Volume 1.20M
Exchange NASDAQ
Shares Outstanding 184.52B
Market Cap 4.54B
Div & Yield N.A. (N.A)
'Mad Money' Lightning Round: Buy, Buy, Buy RR Donnelley

'Mad Money' Lightning Round: Buy, Buy, Buy RR Donnelley

Cramer says to wait on Horizon Pharmaceuticals and avoid United States Steel.

Athenahealth and Horizon Pharma Shares Can Still Move Higher -- Here's Why

Athenahealth and Horizon Pharma Shares Can Still Move Higher -- Here's Why

Athenahealth and Horizon Pharma stock still have plenty of upside left even after their recent rallies. Here's a look at the dynamics propelling these two health sector standouts.

Why Biotech Has Bottomed

Investors should ignore the temporary issues that have knocked the sector down.

Why Biotech Has Bottomed

Why Biotech Has Bottomed

Investors should ignore the temporary issues that have knocked the sector down.

Perilous Reversal Watch: Horizon Pharma (HZNP)

Perilous Reversal Watch: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

Horizon Pharma (HZNP) Is Today's Strong On High Volume Stock

Horizon Pharma (HZNP) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a strong on high relative volume candidate

INVESTOR NOTICE: Khang & Khang LLP Announces An Investigation Of Claims Against Horizon Pharma Plc And Advises Shareholders To Contact The Firm

INVESTOR NOTICE: Khang & Khang LLP Announces An Investigation Of Claims Against Horizon Pharma Plc And Advises Shareholders To Contact The Firm

Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Horizon Pharma plc ("Horizon" or the "Company") (NASDAQ: HZNP).

Before The Move: Watch Endo Into FDA Action Date Tomorrow

Before The Move: Watch Endo Into FDA Action Date Tomorrow

Drugmaker Endo and partner BioDelivery Sciences have a key pipeline event coming soon, possibly tomorrow.

Horizon Pharmaceutical (HZNP) Stock Tumbles on Use of Specialty Pharmacies

Horizon Pharmaceutical (HZNP) Stock Tumbles on Use of Specialty Pharmacies

Horizon Pharmaceutical (HZNP) stock is declining in afternoon trading, as it and Valeant Pharmaceuticals are scrutinized for their use of specialty pharmacies.

Targets of Market Hatred Can Change Daily

It used to be industrials, now it's health care.

Valeant Plunges After Citron Claims To Have 'Smoking Gun'

Valeant Plunges After Citron Claims To Have 'Smoking Gun'

Short-selling research firm Citron Research claims Philidor Rx and R&O, which both have links to Valeant VRX, are the same company and share management...

Horizon Pharma (HZNP) Is Today's Dead Cat Bounce Stock

Horizon Pharma (HZNP) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "dead cat bounce" (down big yesterday but up big today) candidate

HZNP SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Horizon Pharma Plc And Certain Officers And Directors

HZNP SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Horizon Pharma Plc And Certain Officers And Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of Horizon Pharma plc ("Horizon Pharma" or the "Company") (NASDAQGS:HZNP) concerning possible violations of federal securities laws by the Company...

Jim Cramer -- Microsoft, IBM Should Have Their Eyes on the Buys

Jim Cramer -- Microsoft, IBM Should Have Their Eyes on the Buys

If you ask Jim Cramer (and social media users did), Microsoft should acquire Salesforce, IBM should grab Box, pharmaceuticals have a political problem, and there's no substitute for Berkshire Hathaway.

Jim Cramer Says Tech Giants Microsoft, IBM Should Make Acquisitions

Jim Cramer Says Tech Giants Microsoft, IBM Should Make Acquisitions

Jim Cramer says Microsoft (MSFT) will report a decent quarter, thanks to Windows 10, but he wishes the company would make an acquisition.

Horizon Pharma (HZNP) In A Perilous Reversal

Horizon Pharma (HZNP) In A Perilous Reversal

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

A Small Pharma Stock With Big Potential

A Small Pharma Stock With Big Potential

Pernix looks poised for a strong 2016.

Horizon Pharma (HZNP) Strong On High Relative Volume Today

Horizon Pharma (HZNP) Strong On High Relative Volume Today

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a strong on high relative volume candidate

How to Build a Good Foundation in Biotechs

How to Build a Good Foundation in Biotechs

A so-called "pyramid strategy" can help you enter the depressed sector.

Perilous Reversal Watch: Horizon Pharma (HZNP)

Perilous Reversal Watch: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

Horizon Pharma (HZNP) Is Today's Dead Cat Bounce Stock

Horizon Pharma (HZNP) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "dead cat bounce" (down big yesterday but up big today) candidate

Jim Cramer's 'Mad Money' Recap: Here's the Silver Lining Behind the Dark Market Cloud

Jim Cramer's 'Mad Money' Recap: Here's the Silver Lining Behind the Dark Market Cloud

Stocks get cheaper as they head lower and every day we're inching closer to a bottom, Cramer says.

Hedge Funds Doing Battle Over Ailing Stocks

There's blood in the water.

Horizon Pharma (HZNP): Today's Weak On High Volume Stock

Horizon Pharma (HZNP): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a weak on high relative volume candidate

The Biotechs Are Being Taken Out and Shot

All you can do is wait until they bottom out.

Horizon and ANI Appeal in Pharma Selloff

Horizon and ANI Appeal in Pharma Selloff

Some smaller biotechs offer good value at current levels.

Today's Dead Cat Bounce Stock: Horizon Pharma (HZNP)

Today's Dead Cat Bounce Stock: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "dead cat bounce" (down big yesterday but up big today) candidate

Market Wrap: Stocks Sink Across the Board

Materials and technology names led the way down on the session.

Horizon Pharma (HZNP) Showing Signs Of Being A Roof Leaker

Horizon Pharma (HZNP) Showing Signs Of Being A Roof Leaker

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate

TheStreet Quant Rating: B- (Buy)